Logo image
Challenges Implementing Lung Cancer Screening in Federally Qualified Health Centers
Journal article   Peer reviewed

Challenges Implementing Lung Cancer Screening in Federally Qualified Health Centers

Steven B Zeliadt, Richard M Hoffman, Genevieve Birkby, Jan M Eberth, Alison T Brenner, Daniel S Reuland and Susan A Flocke
American journal of preventive medicine, Vol.54(4), pp.568-575
04/2018
DOI: 10.1016/j.amepre.2018.01.001
PMCID: PMC8483158
PMID: 29429606
url
https://www.ncbi.nlm.nih.gov/pmc/articles/8483158View
Open Access

Abstract

The purpose of this study is to identify issues faced by Federally Qualified Health Centers (FQHCs) in implementing lung cancer screening in low-resource settings. Medical directors of 258 FQHCs serving communities with tobacco use prevalence above the median of all 1,202 FQHCs nationally were sampled to participate in a web-based survey. Data were collected between August and October 2016. Data analysis was completed in June 2017. There were 112 (43%) FQHC medical directors or surrogates who responded to the 2016 survey. Overall, 41% of respondents were aware of a lung cancer screening program within 30 miles of their system's largest clinic. Although 43% reported that some providers in their system offer screening, it was typically at a very low volume (less than ten/month). Although FQHCs are required to collect tobacco use data, only 13% indicated that these data can identify patients eligible for screening. Many FQHCs reported important patient financial barriers for screening, including lack of insurance (72%), preauthorization requirements (58%), and out-of-pocket cost burdens for follow-up procedures (73%). Only 51% indicated having adequate access to specialty providers to manage abnormal findings, and few reported that leadership had either committed resources to lung cancer screening (12%) or prioritized lung cancer screening (12%). FQHCs and other safety-net clinics, which predominantly serve low-socioeconomic populations with high proportions of smokers eligible for lung cancer screening, face significant economic and resource challenges to implementing lung cancer screening. Although these vulnerable patients are at increased risk for lung cancer, reducing patient financial burdens and appropriately managing abnormal findings are critical to ensure that offering screening does not inadvertently lead to harm and increase disparities.
Early Detection of Cancer - methods Safety-net Providers - statistics & numerical data Humans Middle Aged Smokers - statistics & numerical data Ambulatory Care Facilities - economics Physician Executives - statistics & numerical data Mass Screening - methods Tobacco Use - adverse effects Socioeconomic Factors Health Resources - statistics & numerical data Mass Screening - legislation & jurisprudence Lung Neoplasms - etiology Vulnerable Populations - statistics & numerical data Poverty - statistics & numerical data Early Detection of Cancer - economics Health Plan Implementation - statistics & numerical data Healthcare Disparities - statistics & numerical data Ambulatory Care Facilities - statistics & numerical data Safety-net Providers - economics Mass Screening - economics Health Expenditures - statistics & numerical data Health Plan Implementation - economics Mass Screening - organization & administration Tobacco Use - epidemiology Safety-net Providers - organization & administration Healthcare Disparities - economics Aged Lung Neoplasms - diagnosis Health Care Surveys - statistics & numerical data

Details

Metrics

Logo image